SCHEMBL16264012

SCHEMBL16264012

COc1ccc(CC2COc3cc(OC)c(OC)c(OC)c3C2=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.60
MAPT P10636 3/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
HPGD P15428 2/20 0.57
USP2 O75604 2/20 0.57
ALOX15 P16050 2/20 0.57
ALOX12 P18054 2/20 0.57
ALDH1A1 P00352 1/20 0.57
TP53 P04637 1/20 0.57
MAOB P27338 4/20 0.49
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16246533 0.89 MAOB (0.52) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL20329876 0.89 CYP3A4 (0.65) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
Urgineanin E SCHEMBL31461025 0.86 CYP3A4 (0.56) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL17547637 0.86 CYP3A4 (0.58) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL17536649 0.86 CYP3A4 (0.67) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL30368835 0.86 CYP3A4 (0.67) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL17547638 0.84 CYP3A4 (0.50) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL16264014 0.83 CYP3A4 (0.72) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL16263997 0.83 CYP3A4 (0.49) CYP3A4MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6276358 0.80 MAPT (0.61) CYP3A4MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014182695-A1 COMPOUNDS FOR TREATMENT OF ANGIOGENESIS-MEDIATED DISEASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2014-11-13 WO disclosed